CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income	$ 230,648	$ 339,255	$ 236,288
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of acquisitions:
Depreciation	122,048	112,149	106,219
Amortization of intangible assets	15,282	15,610	16,216
Amortization of debt issuance costs	1,117	950	754
Share-based compensation expense	30,911	36,287	33,205
Deferred income taxes	(13,349)	(39,225)	21,459
Investment (gain) loss	(19,398)	16,225	(37,896)
(Gain) loss on disposal of property, plant and equipment	(2,045)	(3,626)	243
Other	(6,713)	(4,016)	1,239
Changes in operating assets:
Change in accounts receivable	(2,611)	(20,163)	(52,721)
Change in inventory	(28,947)	(29,675)	(43,038)
Change in other operating assets	(17,971)	1,847	(25,445)
Changes in operating liabilities:
Change in accounts payable	(2,165)	(50,076)	55,628
Change in accrued liabilities	(17,749)	31,760	29,352
Change in income tax payable	(9,307)	(8,333)	(1,455)
Change in other operating liabilities	1,163	(6,468)	(1,505)
Net cash flows provided by operating activities	280,914	392,501	338,543
Cash flows from investing activities
Acquisitions, net of cash received	(3)	(83,979)	(157)
Proceeds from disposal of wafer fabrication facility	6,292	19,270	9,939
Receipt of cash for termination of cross currency swap	374	9,429	0
Receipt of insurance recovery	1,413	6,067	0
Purchases of property, plant and equipment	(150,769)	(211,728)	(141,195)
Proceeds from sales of property, plant and equipment	2,769	418	3,207
Proceeds from short-term investments	6,157	8,002	7,328
Purchases of short-term investments	(9,323)	(9,361)	(7,567)
Purchases of equity securities	(17,901)	(4,051)	(15,106)
Other	2,669	670	(678)
Net cash and cash equivalents used by investing activities	(158,322)	(265,263)	(144,229)
Cash flows from financing activities
Advances on lines of credit and short-term debt	29,036	114,291	21,862
Repayments on lines of credit and short-term debt	(24,509)	(93,498)	(146,372)
Proceeds from long-term debt	25,204	372,751	557,882
Repayments of long-term debt	(154,019)	(505,746)	(586,001)
Debt issuance costs	(948)	(134)	(673)
Net proceeds from the issuance of common stock	0	140	4,337
Repayment of and proceeds from finance lease obligation	(115)	(69)	(291)
Taxes paid related to net share settlement	(15,637)	(12,300)	(14,823)
Net changes in noncontrolling interests	(3,647)	(1,160)	5,631
Other	(88)	12	7
Net cash and cash equivalents used in financing activities	(144,723)	(125,713)	(158,441)
Effect of exchange rate changes on cash and cash equivalents	(485)	(27,244)	10,416
Change in cash and cash equivalents, including restricted cash	(22,616)	(25,719)	46,289
Cash and cash equivalents, beginning of period, including restricted cash	341,099	366,818	320,529
Cash and cash equivalents, end of period, including restricted cash	318,483	341,099	366,818
Supplemental Cash Flow Information
Interest paid during the period	4,607	7,355	6,944
Taxes paid during the period	97,668	88,687	56,077
Non-cash investing and financing activities:
Accounts payable balance related to the purchase of property, plant and equipment	14,602	30,486	24,256
Dividend payable balance to noncontrolling interests	$ 100	$ 0	$ 0